date
acquir
immun
defici
syndrom
aid
remain
fatal
diseas
limit
therapeut
option
past
year
claim
live
million
mostli
develop
countri
lead
caus
infectionrel
death
mani
countri
thu
surviv
rate
import
indic
evalu
longterm
cur
effect
treatment
diseas
china
numer
infecti
diseas
sever
acut
respiratori
syndrom
sar
influenza
viru
subtyp
enceph
hepat
success
treat
tcm
togeth
varieti
clinic
measur
accord
theori
behind
tcm
aid
infecti
diseas
invas
pathogen
caus
imbal
yin
yang
disharmoni
intern
pathophysiolog
function
extern
natur
environ
tcm
use
treat
aid
mani
year
effect
demonstr
surrog
outcom
measur
reduc
hiv
viral
load
increas
count
improv
immun
amelior
symptom
sign
improv
healthrel
qualiti
life
counteract
effect
antiretrovir
drug
report
especi
longterm
studi
surviv
rate
tcmtreat
aid
patient
publish
follow
literatur
review
tcm
treatment
human
immunodefici
viru
aid
hivaid
believ
patient
benefit
tcm
improv
surviv
rate
main
reason
follow
first
hiv
chronic
condit
long
incub
period
aid
present
make
earli
treatment
vital
improv
surviv
rate
efficaci
combin
antiretrovir
therapi
cart
compromis
risk
sideeffect
drug
resist
tcm
role
treat
patient
cart
longer
option
second
tcm
embrac
holist
approach
chines
medicin
practition
often
treat
patient
use
highli
individu
intervent
adjust
balanc
yin
yang
harmon
intern
pathophysiolog
function
extern
natur
environ
chang
combin
empathi
psycholog
counsel
consequ
surviv
rate
may
improv
addit
tcm
also
use
adjunct
therapi
fatal
diseas
cancer
suggest
lower
risk
death
benefit
tcm
could
prolong
surviv
includ
inhibitori
activ
mani
chines
herb
hiv
activ
lower
cost
tcm
compar
convent
medicin
posit
immunoregulatori
effect
tcm
last
absenc
suitabl
methodolog
verifi
cur
effect
tcm
laboratori
evid
surviv
rate
patient
hiv
extrapol
clinic
research
past
decad
littl
research
conduct
regard
wherev
present
studi
poor
qualiti
base
small
sampl
size
limit
followup
recent
studi
shown
encourag
hope
trend
exampl
cohort
patient
aid
patient
receiv
chines
herbal
medicin
chm
formula
day
month
surviv
rate
chm
user
chm
nonus
increas
surviv
probabl
chm
user
confid
interv
p
death
patient
receiv
chm
month
follow
treatment
survivor
experienc
sever
advers
event
progress
diseas
result
show
chm
may
benefici
improv
longterm
surviv
patient
aid
howev
shortfal
studi
eg
sampl
method
clearli
describ
differ
effect
confound
cart
use
count
hiv
plasma
load
complic
psycholog
state
famili
incom
baselin
chm
user
nonus
adequ
consid
anoth
studi
compris
peopl
live
hiv
plhiv
personmonth
follow
patient
die
year
total
mortal
rate
studi
period
per
personyear
lower
global
rate
retrospect
studi
main
critic
absenc
control
group
discount
conclus
tcm
could
increas
surviv
rate
lengthen
life
span
plhiv
conclus
chines
herbal
medicin
may
improv
longterm
surviv
patient
hivaid
robust
research
use
multicent
doubleblind
random
control
studi
requir
